Atea Pharmaceuticals Stock Price History
| AVIR Stock | USD 3.17 0.04 1.28% |
Below is the normalized historical share price chart for Atea Pharmaceuticals extending back to October 30, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Atea Pharmaceuticals stands at 3.17, as last reported on the 21st of March, with the highest price reaching 3.20 and the lowest price hitting 3.13 during the day.
If you're considering investing in Atea Stock, it is important to understand the factors that can impact its price. Atea Pharmaceuticals secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of standard deviation over the last 3 months. Atea Pharmaceuticals exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Atea Pharmaceuticals' risk adjusted performance of 0.0556, and Mean Deviation of 1.77 to double-check the risk estimate we provide.
At this time, Atea Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 03/21/2025, Common Stock Shares Outstanding is likely to grow to about 86.7 M, while Other Stockholder Equity is likely to drop slightly above 690.5 M. . At this time, Atea Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 03/21/2025, Price To Book Ratio is likely to grow to 0.68, while Price Earnings Ratio is likely to drop (1.76). Atea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of October 2020 | 200 Day MA 3.3953 | 50 Day MA 3.104 | Beta 0.183 |
Atea |
Sharpe Ratio = -0.0089
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVIR |
Estimated Market Risk
| 2.32 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Atea Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atea Pharmaceuticals by adding Atea Pharmaceuticals to a well-diversified portfolio.
Price Book 0.6178 | Enterprise Value Ebitda (260.47) | Price Sales 1.9026 | Shares Float 67 M | Wall Street Target Price 7.0667 |
Atea Pharmaceuticals Stock Price History Chart
There are several ways to analyze Atea Stock price data. The simplest method is using a basic Atea candlestick price chart, which shows Atea Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 3, 2025 | 3.52 |
| Lowest Price | March 3, 2025 | 2.9 |
Atea Pharmaceuticals March 21, 2025 Stock Price Synopsis
Various analyses of Atea Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Atea Stock. It can be used to describe the percentage change in the price of Atea Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Atea Stock.| Atea Pharmaceuticals Price Rate Of Daily Change | 1.01 | |
| Atea Pharmaceuticals Price Daily Balance Of Power | 0.57 | |
| Atea Pharmaceuticals Price Action Indicator | 0.02 |
Atea Pharmaceuticals March 21, 2025 Stock Price Analysis
Atea Stock Price History Data
The price series of Atea Pharmaceuticals for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.62 with a coefficient of variation of 4.53. The prices are distributed with arithmetic mean of 3.13. The median price for the last 90 days is 3.12. The company had 1:6 stock split on 9th of November 2012. Atea Pharmaceuticals issued dividends on 2012-11-09.| Open | High | Low | Close | Volume | ||
03/21/2025 | 3.17 | 3.20 | 3.13 | 3.17 | ||
| 03/19/2025 | 3.17 | 3.20 | 3.13 | 3.17 | 163,630 | |
| 03/18/2025 | 3.09 | 3.18 | 3.05 | 3.17 | 203,034 | |
| 03/17/2025 | 3.07 | 3.15 | 3.04 | 3.13 | 222,480 | |
| 03/14/2025 | 3.09 | 3.11 | 3.06 | 3.08 | 172,232 | |
| 03/13/2025 | 3.12 | 3.21 | 3.03 | 3.06 | 193,371 | |
| 03/12/2025 | 2.93 | 3.14 | 2.90 | 3.10 | 332,927 | |
| 03/11/2025 | 2.90 | 2.92 | 2.82 | 2.92 | 343,462 | |
| 03/10/2025 | 2.96 | 3.02 | 2.88 | 2.92 | 293,717 | |
| 03/07/2025 | 2.89 | 3.05 | 2.89 | 2.99 | 374,547 | |
| 03/06/2025 | 2.96 | 3.05 | 2.94 | 3.00 | 307,043 | |
| 03/05/2025 | 2.97 | 3.03 | 2.92 | 3.01 | 176,881 | |
| 03/04/2025 | 2.89 | 3.02 | 2.88 | 2.90 | 517,918 | |
| 03/03/2025 | 3.03 | 3.06 | 2.88 | 2.90 | 270,504 | |
| 02/28/2025 | 3.07 | 3.09 | 3.01 | 3.03 | 399,002 | |
| 02/27/2025 | 3.13 | 3.17 | 3.05 | 3.06 | 449,625 | |
| 02/26/2025 | 3.14 | 3.23 | 3.11 | 3.16 | 259,962 | |
| 02/25/2025 | 3.12 | 3.17 | 3.10 | 3.14 | 288,419 | |
| 02/24/2025 | 3.11 | 3.22 | 3.06 | 3.14 | 249,468 | |
| 02/21/2025 | 3.19 | 3.19 | 3.05 | 3.09 | 309,138 | |
| 02/20/2025 | 3.09 | 3.17 | 3.09 | 3.14 | 176,936 | |
| 02/19/2025 | 3.08 | 3.14 | 3.04 | 3.09 | 177,081 | |
| 02/18/2025 | 3.10 | 3.24 | 3.09 | 3.10 | 325,155 | |
| 02/14/2025 | 3.12 | 3.25 | 3.12 | 3.15 | 203,336 | |
| 02/13/2025 | 3.13 | 3.18 | 3.09 | 3.11 | 275,608 | |
| 02/12/2025 | 2.94 | 3.21 | 2.94 | 3.11 | 366,299 | |
| 02/11/2025 | 3.01 | 3.08 | 2.98 | 2.99 | 432,083 | |
| 02/10/2025 | 3.03 | 3.08 | 2.96 | 3.04 | 213,612 | |
| 02/07/2025 | 3.08 | 3.13 | 2.98 | 2.98 | 238,501 | |
| 02/06/2025 | 3.12 | 3.16 | 3.06 | 3.10 | 190,919 | |
| 02/05/2025 | 2.94 | 3.16 | 2.94 | 3.12 | 844,193 | |
| 02/04/2025 | 2.90 | 2.98 | 2.90 | 2.97 | 241,845 | |
| 02/03/2025 | 2.98 | 3.04 | 2.91 | 2.92 | 382,871 | |
| 01/31/2025 | 3.04 | 3.09 | 2.97 | 3.06 | 264,000 | |
| 01/30/2025 | 3.00 | 3.15 | 2.96 | 2.99 | 498,914 | |
| 01/29/2025 | 3.09 | 3.12 | 2.97 | 3.00 | 420,803 | |
| 01/28/2025 | 3.16 | 3.16 | 3.06 | 3.10 | 367,186 | |
| 01/27/2025 | 3.14 | 3.20 | 3.10 | 3.15 | 306,058 | |
| 01/24/2025 | 3.10 | 3.22 | 3.06 | 3.16 | 350,625 | |
| 01/23/2025 | 3.08 | 3.18 | 3.05 | 3.10 | 482,521 | |
| 01/22/2025 | 3.25 | 3.25 | 3.11 | 3.12 | 514,170 | |
| 01/21/2025 | 3.37 | 3.39 | 3.24 | 3.24 | 320,450 | |
| 01/17/2025 | 3.40 | 3.49 | 3.36 | 3.37 | 337,674 | |
| 01/16/2025 | 3.31 | 3.41 | 3.27 | 3.33 | 406,557 | |
| 01/15/2025 | 3.24 | 3.32 | 3.16 | 3.32 | 679,697 | |
| 01/14/2025 | 3.21 | 3.25 | 3.11 | 3.15 | 424,731 | |
| 01/13/2025 | 3.22 | 3.27 | 3.12 | 3.20 | 766,660 | |
| 01/10/2025 | 3.33 | 3.37 | 3.23 | 3.27 | 596,299 | |
| 01/08/2025 | 3.35 | 3.42 | 3.33 | 3.34 | 356,810 | |
| 01/07/2025 | 3.37 | 3.51 | 3.34 | 3.36 | 382,712 | |
| 01/06/2025 | 3.52 | 3.52 | 3.37 | 3.40 | 583,633 | |
| 01/03/2025 | 3.46 | 3.60 | 3.46 | 3.52 | 282,224 | |
| 01/02/2025 | 3.38 | 3.54 | 3.37 | 3.42 | 365,939 | |
| 12/31/2024 | 3.33 | 3.40 | 3.33 | 3.35 | 326,618 | |
| 12/30/2024 | 3.30 | 3.38 | 3.27 | 3.33 | 410,083 | |
| 12/27/2024 | 3.27 | 3.36 | 3.23 | 3.33 | 640,959 | |
| 12/26/2024 | 3.23 | 3.29 | 3.19 | 3.29 | 333,255 | |
| 12/24/2024 | 3.22 | 3.28 | 3.20 | 3.25 | 174,762 | |
| 12/23/2024 | 3.19 | 3.30 | 3.19 | 3.24 | 403,144 | |
| 12/20/2024 | 3.12 | 3.32 | 3.11 | 3.19 | 1,242,722 | |
| 12/19/2024 | 3.16 | 3.23 | 3.10 | 3.13 | 1,377,841 |
About Atea Pharmaceuticals Stock history
Atea Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Atea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Atea Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Atea Pharmaceuticals stock prices may prove useful in developing a viable investing in Atea Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 84.3 M | 86.7 M | |
| Net Loss | -104.3 M | -99.1 M |
Atea Pharmaceuticals Quarterly Net Working Capital |
|
Atea Pharmaceuticals Stock Technical Analysis
Atea Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Atea Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Atea Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Atea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Atea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0556 | |||
| Jensen Alpha | 0.0834 | |||
| Total Risk Alpha | 0.3133 | |||
| Sortino Ratio | 0.0852 | |||
| Treynor Ratio | (0.23) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Atea Stock Analysis
When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.